NCT05999513View on ClinicalTrials.gov

A Relative Bioavailability Study and Food Effect Study of AB521 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 21, 2023

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
Healthy Participants
Interventions
DRUG

casdatifan

Administered as specified in the treatment arm

Trial Locations (1)

68502

Celerion, Inc., Lincoln

Sponsors
All Listed Sponsors
lead

Arcus Biosciences, Inc.

INDUSTRY